Ftse Mib
38.655,09
0,08%
DAX
22.551,43
0,12%
S&P 500
5.954,50
1,59%
NASDAQ
18.847,28
1,63%
Bitcoin
84.974,43
0,72%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Athira Pharma Inc (ATHA) Athira Pharma Inc (ATHA) Notizie

Athira Pharma Inc

ATHA
0,3911
-0,0315 (-7,45%)
01 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/2/202522:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202522:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202522:10EDGAR2Form 8-K - Current report
27/2/202522:05GLOBEAthira Pharma Reports Full Year 2024 Financial Results and..
03/1/202523:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202523:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202502:06EDGAR2Form 144 - Report of proposed sale of securities
03/1/202502:04EDGAR2Form 144 - Report of proposed sale of securities
03/1/202502:02EDGAR2Form 144 - Report of proposed sale of securities
06/12/202423:30GLOBEAthira Pharma Presents Preclinical Data Highlighting..
07/11/202422:10EDGAR2Form 8-K - Current report
07/11/202422:05GLOBEAthira Pharma Reports Third Quarter 2024 Financial Results..
29/10/202405:15EDGAR2Form EFFECT - Notice of Effectiveness
22/10/202413:00GLOBEAthira Pharma to Present Results from Phase 2/3 LIFT-AD..
21/10/202412:24EDGAR2Form S-3 - Registration statement under Securities Act of..
18/10/202422:02EDGAR2Form 8-K - Current report
04/10/202401:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202401:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202401:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/9/202415:00EDGAR2Form 8-K - Current report
17/9/202415:00GLOBEAthira Pharma to Focus on Advancement of ATH-1105 for the..
06/9/202401:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202401:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202401:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202411:50IHMARKETNEWSNvidia Subpoenaed by DOJ, Athira Pharma Shares Plunge 71%..
03/9/202422:01EDGAR2Form 8-K - Current report
03/9/202422:01GLOBEAthira Pharma Announces Topline Results from Phase 2/3..
09/8/202422:05EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
01/8/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202422:10EDGAR2Form 8-K - Current report
01/8/202422:05GLOBEAthira Pharma Reports Second Quarter 2024 Financial Results..
31/7/202414:05GLOBEAthira Pharma Presents Preclinical Data Demonstrating New..
12/6/202413:00GLOBEAthira to Host Webinar Highlighting Potential for..
11/6/202413:00GLOBEAthira Pharma Completes First Cohort in Phase 1 Clinical..
29/5/202422:05EDGAR2Form 8-K - Current report
29/5/202413:00GLOBEAthira Pharma to Participate in Upcoming June Conferences
25/5/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202423:00EDGAR2Form 8-K - Current report
17/5/202423:00GLOBEAthira Pharma Announces Proposed Settlement of Stockholder..
15/5/202422:10EDGAR2Form 8-K - Current report
15/5/202422:05GLOBEAthira Pharma Reports First Quarter 2024 Financial Results..
02/5/202413:00GLOBEAthira Pharma to Participate in Upcoming May Conferences
15/4/202413:00GLOBEAthira Pharma Appoints Javier San Martin, M.D., as Chief..
11/4/202413:00GLOBEAthira Pharma Announces Publication of Preclinical Data..
03/4/202413:00GLOBEAthira Pharma Announces Upcoming Poster Presentation at..
Apertura: 0,4101 Min: 0,3901 Max: 0,415
Chiusura: 0,4226

La tua Cronologia

NASDAQ
ATHA
Athira Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci